Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by biggdoggon Jul 11, 2024 10:56am
113 Views
Post# 36128292

RE:RE:RE:RE:RE:What are these DSU things VM keeps doling out?

RE:RE:RE:RE:RE:What are these DSU things VM keeps doling out?Re Options: They can issue up to 10% of the equity. Based on what I have seen, the independent directors issue these options, and they have never issued 10%. The options issued in 2023 was 2,900,000 or about 1.5% of the issued shares. I am not sure how many total options are issued, but they are not blowing them out, they seem to be conserving them. This is why an independent board is critical for a company like this. There are only 10% allowed total, therefore based on todays number the max that could be issued is 13.9M options. After that no more options are allowed unless options expire or are exercised.
<< Previous
Bullboard Posts
Next >>